Ginkgo Bioworks Holdings (DNA) Shares Outstanding (2019 - 2026)

Ginkgo Bioworks Holdings' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $65.1 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 12.01% year-over-year to $65.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.1 million (up 12.01% YoY) and the FY2025 annual result came in at $61.7 million, up 6.69% from the prior year.
• Shares Outstanding (Entity) was $65.1 million for Q1 2026 at Ginkgo Bioworks Holdings, up from $61.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $65.1 million in Q1 2026 and bottomed at $47874.0 in Q1 2023.
• A 5-year average of $50.7 million and a median of $54.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) slumped 99.89% — and 2024, when it surged 113324.14%.
• Ginkgo Bioworks Holdings' Shares Outstanding (Entity) stood at $42.0 million in 2022, then grew by 27.39% to $53.5 million in 2023, then rose by 8.12% to $57.8 million in 2024, then increased by 6.69% to $61.7 million in 2025, then gained by 5.6% to $65.1 million in 2026.
• Business Quant data shows DNA's Shares Outstanding (Entity) at $65.1 million in Q1 2026, $61.7 million in Q4 2025, and $60.3 million in Q3 2025.